Peter A. Jones
Tracked across 1 events · 6 articles · First seen Sep 21, 2026 · Last active Sep 23, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
The phase 2 EVITA trial, a randomized, double-blind, placebo-controlled study, tested whether high-dose oral vitamin C (1000 mg/day for 12 months) could benefit patients with clonal cytopenia of undetermined significance or lower-risk myeloid malignancies, conditions…
Impact: Co-senior author of the EVITA trial who voiced cautious optimism about vitamin C for intercepting leukemia development.
Sep 21, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Peter A. Jones live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard